Fredrik Widman, VP Corporate Controller at Intuitive Surgical Inc, filed a Form 4 on October 26, 2026, reporting stock option exercises and a sale of common shares that occurred on October 23, 2026, under a Rule 10b5-1 trading plan.

Key Highlights

  • Sale of 4,047 shares: Widman disposed of 4,047 shares of common stock at a weighted average price of $453.2059, with individual transactions ranging from $444.44 to $458.02.
  • Post-transaction ownership: Following all reported transactions, Widman directly held 1,026 shares of common stock.
  • Eleven option exercises: Widman exercised non-qualified stock options across eleven separate tranches on October 23, 2026, acquiring a total of 4,047 shares at exercise prices ranging from $139.52 to $347.4167.
  • Rule 10b5-1 plan: According to the filing, all transactions took place under a trading plan that complies with SEC Rule 10b5-1 and expires on September 15, 2027.
  • Remaining derivative holdings: After the exercises, Widman retained derivative holdings across eleven non-qualified stock option positions, with remaining shares ranging from 526 to 1,134 per option grant.

Fredrik Widman's October 23, 2026 Option Exercises and Share Sale at Intuitive Surgical

According to the Form 4 filed with the SEC on October 26, 2026, Fredrik Widman, serving as VP Corporate Controller at Intuitive Surgical Inc (NASDAQ:ISRG), exercised eleven non-qualified stock option tranches on October 23, 2026, each bearing a different exercise price. The exercise prices ranged from $139.52 to $347.4167 per share, and the shares acquired through these exercises were coded as transaction type "M," indicating option exercises. All transactions were reported as carried out under a Rule 10b5-1 trading plan set to expire September 15, 2027.

Following the acquisitions through option exercise, the filing reports that Widman disposed of 4,047 shares of common stock at a weighted average sale price of $453.2059. The filing details that these shares were sold across multiple price points, from a low of $444.44 to a high of $458.02. The largest single price-range block consisted of 1,447 shares sold at prices between $451.98 and $452.97. The filing notes that Widman undertakes to provide full details of shares sold at each price upon request to the SEC, the issuer, or a security holder.

After all reported transactions, Widman directly held 1,026 shares of common stock. On the derivative side, the filing shows that eleven non-qualified stock option positions remain, each with remaining shares outstanding, with expiration dates ranging from February 15, 2028 to August 26, 2031. These options were granted under the 2010 Incentive Award Plan, with vesting schedules that vary by grant, including 1/8th vesting six months after the grant date with 1/48th monthly thereafter, and other structures as described in the filing footnotes.

What Was Disclosed

Widman's Form 4 reported eleven stock option exercises and one open-market sale on October 23, 2026, all conducted under a Rule 10b5-1 plan. After the transactions, his direct beneficial ownership of common stock stood at 1,026 shares.